CODX vs BMRA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CODX Captures Institutional Edge (2โ2 Pillars ยท 5โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Co-Diagnostics, Inc. Common Stock (CODX) driven by superior Valuation, Momentum & Technical while BMRA counters with relative strength in Growth & Margin, Options & Structure. Fundamentally, CODX trades at 15.4x Forward P/E with -3415.8% operating margin (+94.6% YoY revenue) versus BMRA at N/M Forward P/E and -125.2% operating margin (-8.3% YoY). In options structure, CODX sits in BREAKDOWN (50th %ile IV; Dealer Gamma Walls on Pro) against BMRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CODX Revenue | BMRA Revenue | CODX Op. Margin | BMRA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $0M | $10M | -2741.6% | -46.4% | BMRA |
| FY2020 | $70M | $10M | 55.9% | -41.0% | CODX |
| FY2021 | $100M | $10M | 47.1% | -104.2% | CODX |
| FY2022 | $30M | $20M | -78.8% | -24.0% | BMRA |
| FY2023 | $10M | $10M | -626.9% | -135.3% | BMRA |
| FY2024 | $0M | $10M | -1023.7% | -117.6% | BMRA |
| FY2025 | $0M | $10M | -8058.8% | -96.7% | BMRA |
| FY2026 | N/A | $0M | N/A | -119.5% | BMRA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CODX | BMRA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.3M | $6.0M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | 15.4x | N/M | Lower Multiple | CODX |
| Forward P/E Ratio Valuation | 15.4x | N/M | Lower Multiple | CODX |
| Revenue Growth (YoY) Growth | +94.6% | -8.3% | Higher Growth | CODX |
| Operating Margin (TTM) Profitability | -3415.8% | -125.2% | Higher Margin | BMRA |
| Net Profit Margin Profitability | 0.0% | -115.5% | Higher Margin | CODX |
| Return on Equity (ROE) Capital Efficiency | -192.8% | -113.8% | Higher ROE | BMRA |
| 52-Week Range Position Momentum | 0% ($0โ$14) | 4% ($1โ$3) | Stronger Trend | BMRA |
| Beta / 30D Volatility Risk Regime | 2.92ฮฒ ยท 148% Vol | 0.67ฮฒ ยท 62% Vol | Lower Realized Risk | BMRA |
| Unified Institutional Score Composite Signal | 51.6 / 100 (HOLD) | 44.5 / 100 (HOLD) | Higher Composite | CODX |